Study finds cannabinoids could replace Benzodiazepines very soon

Marijuana NewsMedical Cannabis0 Comments

Forbes recently published an article that discussed marijuana’s potential to be an effective stress reducer.

The study also said the results indicate that marijuana compounds may be more effective and safer in alleviating anxiety than prescription anxiety medication (i.e. Xanax, Klonopin, Valium).

We agree with the results of this study as they are in-line with a study recently conducted by a Canadian marijuana firm.

Canabo Medical (CMM.V: TSX Venture) (CAMDF: OTCQB) is a company leading the marijuana research initiative. The company has been collecting data on how cannabis interacts with or lessens the need for pharmaceutical treatments. Canabo owns and operates CMClinics, Canada’s largest referral-only clinics for medical marijuana.

Canabo Finds Cannabis to be Effective

In April, Canabo Medical Executive Chairman Neil Smith presented the results from its benzodiazepine study which focused on more than 1,500 patients who started medical cannabinoids while on benzodiazepines. The study found that 40% of patients eliminated the use of benzodiazepines within 90 days. This number increased to 45% within a year of cannabis treatment.

Canabo is currently tracking over 3,500 patients who are taking opioids for a large variety of pain and other disorders. Canabo expects to publish peer-reviewed papers on the opioid-cannabinoid relationship later this year.

While the study reported by Forbes focused on marijuana’s potency in reducing the stress response in regular users and compared the stress responses of a group of daily marijuana users to a group of non-users, Canabo’s study was focused on getting people off anxiety medications.

DOJ Preventing Cannabis Research

Earlier this month, The Washington Post reported that the DOJ effectively blocked the Drug Enforcement Administration (DEA) from acting on more than two dozen requests to grow marijuana for research purposes.

In 2016, the DEA began to accept applications to cultivate marijuana for research and as of this month, the agency has 25 proposals to consider; but DEA officials, however advised that they need approval from the DOJ to move forward and the DOJ has not been willing to provide it.

Click here to read the entire article.

Rate this article: 
Select ratingGive it 1/5Give it 2/5Give it 3/5Give it 4/5Give it 5/5
Regional Marijuana News: 

Source: 420Intel – Medical Cannabis

Leave a Reply

Your email address will not be published. Required fields are marked *